Arvinas, Inc. ( ARVN) - Key Metrics
ARVN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.85 | $2.61 | -$0.75 | -$0.75 |
| 2026Q1 | $0.24 | -$0.90 | -$1.08 | -$1.10 |
| 2025Q4 | $0.15 | -$1.04 | -$0.47 | -$0.47 |
| 2025Q3 | $0.57 | -$0.48 | -$0.81 | -$0.81 |
| 2025Q2 | $0.31 | -$0.84 | -$1.31 | -$1.33 |
ARVN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.80 |
| 2026Q1 | 0% | -2.94 |
| 2025Q4 | 0% | -2.85 |
| 2025Q3 | 0% | -4.44 |
| 2025Q2 | 0% | -2.19 |
ARVN
Price: $8.97
52 week price:
Earnings Per Share: 0.26 USD
P/E Ratio: 33.65
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 476209
Market Capitalization: 564.6 million